Back to Search Start Over

Design, construction, and functional characterization of a tRNA neochromosome in yeast.

Authors :
Schindler D
Walker RSK
Jiang S
Brooks AN
Wang Y
Müller CA
Cockram C
Luo Y
García A
Schraivogel D
Mozziconacci J
Pena N
Assari M
Sánchez Olmos MDC
Zhao Y
Ballerini A
Blount BA
Cai J
Ogunlana L
Liu W
Jönsson K
Abramczyk D
Garcia-Ruiz E
Turowski TW
Swidah R
Ellis T
Pan T
Antequera F
Shen Y
Nieduszynski CA
Koszul R
Dai J
Steinmetz LM
Boeke JD
Cai Y
Source :
Cell [Cell] 2023 Nov 22; Vol. 186 (24), pp. 5237-5253.e22. Date of Electronic Publication: 2023 Nov 08.
Publication Year :
2023

Abstract

Here, we report the design, construction, and characterization of a tRNA neochromosome, a designer chromosome that functions as an additional, de novo counterpart to the native complement of Saccharomyces cerevisiae. Intending to address one of the central design principles of the Sc2.0 project, the ∼190-kb tRNA neochromosome houses all 275 relocated nuclear tRNA genes. To maximize stability, the design incorporates orthogonal genetic elements from non-S. cerevisiae yeast species. Furthermore, the presence of 283 rox recombination sites enables an orthogonal tRNA SCRaMbLE system. Following construction in yeast, we obtained evidence of a potent selective force, manifesting as a spontaneous doubling in cell ploidy. Furthermore, tRNA sequencing, transcriptomics, proteomics, nucleosome mapping, replication profiling, FISH, and Hi-C were undertaken to investigate questions of tRNA neochromosome behavior and function. Its construction demonstrates the remarkable tractability of the yeast model and opens up opportunities to directly test hypotheses surrounding these essential non-coding RNAs.<br />Competing Interests: Declaration of interests J.D.B. is a Founder and Director of CDI Labs, Inc.; a Founder of and consultant to Neochromosome, Inc.; a Founder, SAB member of, and consultant to ReOpen Diagnostics, LLC; and serves or served on the Scientific Advisory Board of the following: Logomix, Inc., Modern Meadow, Inc., Rome Therapeutics, Inc., Sample6, Inc., Sangamo, Inc., Tessera Therapeutics, Inc., and the Wyss Institute.<br /> (Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1097-4172
Volume :
186
Issue :
24
Database :
MEDLINE
Journal :
Cell
Publication Type :
Academic Journal
Accession number :
37944512
Full Text :
https://doi.org/10.1016/j.cell.2023.10.015